Cargando…
The who, what and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study
PURPOSE: In a diagnostic exome sequencing study (NCGENES), we investigated adult patients’ intentions to request six categories of secondary findings (SFs) with low or no medical actionability and correlates of their intentions. METHODS: At enrollment, eligible participants (n=152) completed measure...
Autores principales: | Rini, Christine, Khan, Cynthia M., Moore, Elizabeth, Roche, Myra I., Evans, James P., Berg, Jonathan S., Powell, Bradford C., Corbie-Smith, Giselle, Foreman, Ann Katherine M., Griesemer, Ida, Lee, Kristy, O’Daniel, Julianne M., Henderson, Gail E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920790/ https://www.ncbi.nlm.nih.gov/pubmed/29261173 http://dx.doi.org/10.1038/gim.2017.176 |
Ejemplares similares
-
Factors influencing NCGENES research participants’ requests for non-medically actionable secondary findings
por: Roche, Myra I., et al.
Publicado: (2018) -
Genomic Knowledge in the Context of Diagnostic Exome Sequencing: Changes over Time, Persistent Subgroup Differences, and Associations with Psychological Sequencing Outcomes
por: Rini, Christine, et al.
Publicado: (2019) -
Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial
por: Staley, Brooke S., et al.
Publicado: (2021) -
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
por: Berg, Jonathan S., et al.
Publicado: (2016) -
Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making
por: DeCristo, Daniela M., et al.
Publicado: (2021)